Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia

ClinicalTrials.gov ID: NCT02706795

Public ClinicalTrials.gov record NCT02706795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02706795
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
37 participants

Conditions and interventions

Interventions

  • DaxibotulinumtoxinA Biological

Biological

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Dec 6, 2016
Completion
Jul 16, 2017
Last update posted
Nov 5, 2019

2015 – 2017

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
The Parkinson's & Movement Disorder Institute Fountain Valley California 92708
Colorado Springs Neurological Associates Colorado Springs Colorado 80907
University of Florida Center for Movement Disorders & Neurorestoration Gainesville Florida 32607
Precision Research Organization Miami Lakes Florida 33016
University of South Florida Tampa Florida 33613
Emory University Atlanta Georgia 30329
Rush University Medical Center Chicago Illinois 60612
Kansas City Bone & Joint Clinic Overland Park Kansas 66211
The NeuroMedical Center Clinic Baton Rouge Louisiana 70810
Wake forest Baptist Health Winston-Salem North Carolina 27157
Riverhills Healthcare, Inc. Cincinnati Ohio 45212
Coastal Neurology Port Royal South Carolina 29935
Parkinson's Disease Center and Movement Disorder Clinic Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02706795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02706795 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →